Proteomic Biomarkers of Preterm Birth Risk in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Biomarker Database Integration

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Galazis, Nicolas ^a   Docheva, Nikolina ^a   Nicolaides, Kypros H ^b,c   Atiomo, William ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; CALGRANULIN; CALGRANULIN A; CALGRANULIN B; CALGRANULIN C; FALL 39 PROTEIN; FILAMIN A; FRUCTOSE BISPHOSPHATE ALDOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE A; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN BETA 1; LEUKOCYTE ELASTASE INHIBITOR; LIPOCALIN 1; MACROPHAGE CAPPING PROTEIN; MEMBRANE PROTEIN; MYELOPEROXIDASE; NEUTROPHIL DEFENSIN 1; NEUTROPHIL DEFENSIN 2; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PEROXIREDOXIN 1; PYRUVATE KINASE; PYRUVATE KINASE M1; PYRUVATE KINASE M2; RETINOL BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; TRANSFERRIN; UNCLASSIFIED DRUG; VIMENTIN;

AMNION FLUID; ARTICLE; DISEASE ASSOCIATION; HIGH RISK PREGNANCY; HUMAN; MATERNAL SERUM; MOLECULAR PATHOLOGY; OVARY POLYCYSTIC DISEASE; PREMATURE LABOR; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEOMICS; RISK ASSESSMENT; SYSTEMATIC REVIEW;

DATABASES, FACTUAL; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENE EXPRESSION; HSP27 HEAT-SHOCK PROTEINS; HUMANS; PEROXIREDOXINS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; PYRUVATE KINASE; RISK FACTORS; TRANSFERRIN; VIMENTIN;

EID: 84873828018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053801     Document Type: Article

References (55)

1. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19(1): 41-47.
2. Wild RA, (2002) Long term health consequences of PCOS. Human Reproduction Update 8(3): 231-241.
3. Dunaif A, Thomas A, (2001) Current concepts in the polycystic Ovary Syndrome. Annual Review of Medicine 52: 401-419.
4. Kjerulff LE, Sanchez-Ramos L, Duffy D, (2011) Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol. 204(6): 558.e1-6.
5. Altieri P, Gambineri A, Prontera O, Cionci G, Franchina M, Pasquali R, (2010) Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol. 149(1): 31-6.
6. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, et al. (2006) A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 12(6): 673-83.
7. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A, (2001) Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod. 16(2): 226-9.
8. Saigal S, Doyle LW, (2008) An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 371: 261-269.
9. Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. CMACE: London.
10. McCormick MC, (1985) The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. 312: 82-90.
11. Goldenberg RL, Culhane JF, Iams JD, Romero R, (2008) Epidemiology and causes of preterm birth. Lancet. 371: 75-84.
12. Anderson NL, Anderson NG, (1998) Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis. 11: 1853-61.
13. Atiomo WU, Khalid S, Ziauddin A, Tooth D, Layfield R, (2009) Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome. Special Report. Expert Rev Proteomics 6(5): 469-99.
14. Parker LA, Gómez Saez N, Lumbreras B, Porta M, Hernández-Aguado I, (2010) Methodological deficits in diagnostic research using '-omics' technologies: evaluation of the QUADOMICS tool and quality of recently published studies. PLoS One. 5(7): e11419.
15. Choi DH, Lee WS, Won M, Park M, Park HO, et al. (2010) The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis. J Proteome Res 9(9): 4329-36.
16. Insenser M. Martinez-Garcia MA. Montes R. San-Millan JL. Escobar-Morreale HF, (2010) Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation. J Clin Endocrinol Metab95(8): 3863-70.
17. Misiti S, Stigliano A, Borro M, Gentile G, Michienzi S, et al. (2010) J Endocrinol Invest. 33(3): 156-64.
18. Atiomo W. Khalid S. Parameshweran S. Houda M. Layfield R, (2009) Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review. BJOG 116(2): 137-43.
19. Santillan I, Neubeck S, Markert UR, (2010) Comparative proteomic analysis of follicular fluids from patients with different infertility etiologies. American Journal of Reproductive Immunology. Conference: 30th Annual Meeting of the American Society for Reproductive Immunology, ASRI Farmington, PA United States. Conference Publication 63: 52-53.
20. Webber M, Neubeck S, Hoppe I, Markert UR, (2010) Comparative proteomic analysis of follicular fluids from patients with different infertility etiologies. Journal of Reproductive Immunology. Conference: 11th International Congress of Reproductive Immunology Palm Cove, QLD Australia. Conference Publication 86 (1): 56-57.
21. Cox MC, Borro M, Gentile G, De Luca O, Aloe Spiriti MA, et al. (2010) Specific effects exerted by B-lymphoproliferative diseases on peripheral T lymphocytes protein expression. Haematologica. Conference: 15th Congress of the European Hematology Association, EHA Barcelona Spain 95: 176-177.
22. Baek KH, Kim YS, Gu BH, Kim MS, Chung HV, et al. (2010) Apolipoprotein as a novel gene associated with polycystic ovary syndrome. Fertility and Sterility. Conference: Annual Meeting of the American Society for Reproductive Medicine, ASRM Denver, CO United States. 94 4(suppl 1): S197-S198.
23. Ling J, Zhao KK, Cui YG, Li Y, Wang X, et al. (2011) Heat shock protein 10 regulated apoptosis of mouse ovarian granulosa cells. Gynecol Endocrinol. 27 (1) 63-71.
24. Peral B, Camafeita E, Fernandez-Real JM, (2009) Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies. Expert Rev Proteomics; 6 (4): 353-361.
25. Hojlund K, Mogensen M, Sahlin K (2008) Mitochondrial Dysfunction in Type 2 Diabetes and Obesity. Endocrinol Metab Clin North Am. 37 (3) 713.
26. Buhimschi IA, Christner R, Buhimschi CS, (2005) Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG. 112(2): 173-81.
27. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob P, et al. (2004) Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 292(4): 462-9.
28. Rüetschi U, Rosén A, Karlsson G, Zetterberg H, Rymo L, et al. (2005) Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res. 4(6): 2236-42.
29. Cobo T, Palacio M, Navarro-Sastre A, RIbes A, Bosch J, et al. (2009) Predictive value of combined amniotic fluid proteomic biomarkers and interleukin-6 in preterm labor with intact membranes. Am J Obstet Gynecol. 200(5): 499.e1-6.
30. Romero R, Kusanovic JP, Gotsch F, Erez O, Vaisbuch E, et al. (2010) Isobaric labeling and tandem mass spectrometry:a novel approach for profiling and quantifying proteins differentially expressed inamniotic fluid in preterm labor with and without intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med (234) (): 261-80.
31. Bujold E, Romero R, Kusanovic JP, Erez O, Gotch F, et al. (2008) Proteomic profiling of amniotic fluid in preterm labor using twodimensional liquid separation and mass spectrometry. J Matern Fetal Neonatal Med. 21(10): 697-713.
32. Pereira L, Reddy AP, Alexander AL, Lu X, Lapidus JA, et al. (2010) Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serumpeptidome among women in preterm labor. Am J Obstet Gynecol. 202(6): 555.e1-10.
33. Stella CL, Bennett MR, Devarajan P, Greis K, Wyder M, et al. (2009) Preterm labor biomarker discovery in serum using 3 proteomic profiling methodologies. Am J Obstet Gynecol. 201(4): 387.e1-13.
34. Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, et al. (2007) Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med. 4(1): e18.
35. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3): 89-95.
36. Gupta V, Bamezai RN, (2010) Human pyruvate kinase M2: a multifunctional protein. Protein Sci. 19(11): 2031-44.
37. Shafrir E, Diamant YZ, (1978) Regulation of placental enzymes of the carbohydrate and lipid metabolic pathways. Ciba Found Symp. (63): 161-79.
38. Diamant YZ, Mayorek N, Neumann S, Shafrir E, (1975) Enzymes of glucose and fatty acid metabolism in early and term human placenta. Am J Obstet Gynecol. 121(1): 58-61.
39. Diamant YZ, Kissilevitz R, Shafrir E, (1984) Changes in activity of enzymes related to glycolysis, gluconeogenesis and lipogenesis in placentae from diabetic women. Placenta. 5(1): 55-60.
40. Diamant YZ, Shafrir E, (1978) Placental enzymes of glycolysis, gluconeogenesis and lipogenesis in the diabetic rat and in starvation. Comparison with maternal and foetal liver. Diabetologia (156) (): 481-5.
41. Fushinobu S, Nishimasu H, Hattori D, Song HJ, Wakagi T, (2011) Structural basis for the bifunctionality of fructose-1,6-bisphosphate aldolase/phosphatase. Nature. 478(7370): 538-41.
42. Katsumoto T, Mitsushima A, Kurimura T, (1990) The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction. Biol Cell 68 (2): 139-46.
43. Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas DT, (2007) Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts. Crit Rev Clin Lab Sci 44(4): 339-63.
44. Hamilton SM, Bayer CR, Stevens DL, Lieber RL, Bryant AE, (2008) Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J Infect Dis 198(11): 1692-8.
45. Briggs DA, Sharp DJ, Miller D, Gosden RG, (1999) Transferrin in the developing ovarian follicle: evidence for de-novo expression by granulosa cells. Mol. Hum. Reprod. 5 (12): 1107-1114.
46. Kralova A, Svetlikova M, Madar J, Ulcova-Gallova Z, Bukovsky A, et al. (2008) Differential transferrin expression in placentae from normal and abnormal pregnancies: a pilot study. Reprod Biol Endocrinol 6: 27.
47. Lindquist L, Craig EA, (1998) The heat shock protein. Rev. Genet. 22: 631-77.
48. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA, (1992) Biological and Clinical Implications of Heat Shock Protein 27000 (Hsp27): a Review. Natl Cancer Inst 85: 1558-1570.
49. Neumann CA, Cao J, Manevich Y, (2009) Peroxiredoxin 1 and its role in cell signaling. Cell Cycle (824) (): 4072-8.
50. Ma Y, Zhang P, Wang F, Qin H, (2012) Searching for consistently reported up- and down-regulated biomarkers in colorectal cancer: a systematic review of proteomic studies. Mol Biol Rep. 39(8): 8483-90.
51. Wang H, Gottfries J, Barrenäs F, Benson M, (2011) Identification of novel biomarkers in seasonal allergic rhinitis by combining proteomic, multivariate and pathway analysis. PLoS One. 6(8): e23563.
52. Ptolemy P, Rifai N (2010) What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema. Scand J Clin Lab Invest Suppl (Suppl 242): 6-14.
53. Veenstra TD (2011) Where are all the biomarkers. Expert Rev. Proteomics 8(6),681-683.
54. Dudley JT, Butte AJ, (2009) Identification of Discriminating Biomarkers For Human Disease Using Integrative Network Biology. Pacific Symposium On Biocomputing 14: 27-38.
55. Mayeux R, (2004) Biomarkers: Potential Uses and Limitations. NeuroRx. 1(2): 182-188.